Cryomass Technologies Inc. (CRYM)

0.0385 +0.0022 (+6.09%) At close: 02:19PM EDT

Cryomass Technologies Inc.

1001 Bannock Street
Suite 612
Denver, CO 80204
United States
303 416 7208
https://cryomass.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Christian Noel	CEO & Director	387k	N/A	1977
Mr. Philip Blair Mullin B.A., BA, M.B.A., MBA	Chief Financial Officer	290.4k	N/A	1954
Ms. Patricia I. Kovacevic	General Counsel, Corporate Secretary & Head of External Affairs	266.2k	N/A	1972
Mr. Ryan Smith	Chief Operating Officer of Good Meds	N/A	N/A	N/A
Mr. Stephen Schroeder	Consultant	N/A	N/A	N/A
Ms. Caroline Lenardon	Consultant	N/A	N/A	N/A
Ms. Janice Matthews	Consultant	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cryomass Technologies Inc. designs, sells, and commercializes cryo-mechanical system for the handling of harvested hemp, cannabis, and other high-value plants in the United States. The company was formerly known as Andina Gold Corp. and changed its name to Cryomass Technologies Inc. in August 2021. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado.

Corporate governance

Cryomass Technologies Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.